"We have issued an official invitation to the Iraqi Ministry of Health and all inspection committees to review the research and development processes of the plant and move on to the opening of the project,"said the director of the Laboratory, engineer Haidar Shaker Rashid.
"The delegation consists of three committees, namely the engineering committee responsible for evaluating the progress schedule of the project, in which the completion rate reached 98% in terms of engineering works, and there are only some minor finishing works remaining, including the electrical connection that will be carried out by device manufacturers,"he added.
"The second committee is the technical committee responsible for giving the green light to the research and development phase of the product, while the task of the Third Committee is to monitor the performance of laboratories and Drug Control,"he added.
The Al-Joud intravenous solutions factory is one of the public service projects provided by the Al-Abbas's (p) holy shrine to the Iraqi citizen to cover the shortage in the health sector and contribute to the development of pharmaceutical industries in Iraq, according to Rashid.